Purpose: Corneal tomography is used to assess progression of keratoconus and to direct clinical decisions regarding corneal crosslinking. The purpose of this study was to analyze the variability of repeated Scheimpflug-tomography (Pentacam Classic; Oculus, Wetzlar, Germany) measurements of keratoconic eyes in a clinical setting and to assess the validity of such measurements as a clinical decision-making tool.
K
eratoconus is characterized by bilateral but asymmetric, pathological thinning and bulging of the cornea that may lead to visual impairment. 1 The risk of progression and the progression rate are higher in children and adolescents younger than 19 years. 2 The progression rate declines considerably after the age of 20 years, and in the natural course of the disease in most cases, progression is halted between 30 and 40 years of age. 3 Spectacles, rigid gaspermeable contact lenses, and insertion of corneal ring segments are treatment modalities commonly applied to improve visual function. These treatment modalities do not, however, stop progression. 4 In 2003, Wollensak et al 5 presented corneal crosslinking (CXL) as a new treatment modality using riboflavin and UV light to halt progression of keratoconus and ultimately prevent the need for a corneal transplant. CXL is recommended for progressive keratoconus at any age. Side effects of CXL are relatively benign and rare. 6 However, patients undergoing the most efficient form of CXL, the so-called epi-off CXL, which includes removal of the corneal epithelium, frequently report moderate-tosevere postoperative pain despite advanced measures to relieve pain. 7 Corneal topography has been introduced in the mid 1990s as a valuable tool for assessing progression in keratoconus. 8 Modern versions of the technique, such as the Pentacam tomography system (Oculus, Wetzlar, Germany), create topographical maps over both the front and back surfaces, as well as pachymetry maps of the cornea. 9 The high repeatability of measurements of the Pentacam system in eyes with healthy corneas is well documented. [9] [10] [11] [12] [13] [14] Repeatability in eyes with higher refractive error, ectatic, and irregular corneas, however, is much poorer. 14, 15 Despite a general consensus that progression of keratoconus should be defined by the change of several topographic parameters over a period, one of the most common definitions of progression in clinical trials has been an increase only in one parameter, namely the maximum keratometry reading (Kmax), by 1 diopter (D) or more during different periods of follow-up (FU). 4, 16 Scheimpflug tomography measurements can have poor repeatability even in healthy eyes. McAlinden et al 17 found poor repeatability for front surface meridional and axial maps for the Pentacam HR tomography model in 100 healthy eyes of 100 subjects. The Global Consensus on Keratoconus and Ectatic Diseases also concluded that no clinically adequate classification system for keratoconus currently exists. 4 The aim of this study was to investigate the variability of tomographic measurements in our study group and to quantify its effects on progression analysis and clinical decision making regarding CXL treatment. We also studied whether measurement variation of 3 consecutive measurements of a selected keratometric value (SimKast) could predict progression as early as at the first visit.
MATERIALS AND METHODS
In this study, we analyzed the repeatability of tomography results of parameters generated by the Pentacam Classic device (Pentacam, Oculus) in a group of 80 keratoconic eyes of 45 patients. The study group represents a "reallife" scenario of a group of patients seen in the cornea and external disease department of a tertiary referral center. The study concentrates on keratometry readings (K-readings) of the anterior surface of the cornea and minimum corneal thickness (MT). As in other trials studying the efficacy of CXL, a simplified definition for significant progression was used.
All patients in this study were examined during the ongoing recruitment process of a randomized controlled clinical trial aiming to study the efficacy of CXL in progressive keratoconus. The trial was approved by the regional ethical review committee (DNR 949-11; clinical trial identifier NCT01604135) and adheres to the Declaration of Helsinki.
Inclusion criteria were age 17 to 35 years, diagnosis of keratoconus and the ability to stop contact lens wear (corneal and scleral rigid gas-permeable as well as soft contact lenses) at least 2 weeks before examination. It was also mandatory that 3 consecutive topographic examinations of each eye with an approved quality rating ("OK" rating ) at the first and second visits could be obtained. Exclusion criteria were a history of corneal surgery, a history of ocular herpes simplex infection, MT ,400 mm, recurrent corneal erosions, other corneal (eg, endothelial) or conjunctival diseases, and severe scarring or striae of the cornea. Baseline characteristics of the patients and eyes are summarized in Table 1 .
In all, 80 keratoconic eyes of 45 patients (age 16-32 years) were examined at baseline (first visit) and after a FU interval of 3 to 6 months (second visit) using 3 consecutive same-day Scheimpflug tomography measurements (Pentacam Classic, Oculus).
Analysis by the Pentacam System
The following parameters taken from the sagittal curvature map of the Pentacam system were assessed: anterior surface simulated keratometry astigmatism (SimKast); maximum SimK (SimKmax); average SimK (SimKave); maximum K-readings on the 3-mm (Kmax3) and 5-mm (Kmax5) rings; and maximum K-reading (Kmax). In addition, MT was recorded. Table 2 summarizes the tomographic characteristics of the eyes studied. At each visit, both eyes were examined with 3 consecutive tomography images. The measurements were taken by either of 2 experienced examiners (B.S. or U.M.). The tomography machine was calibrated according to the manufacturer's recommendations. All measurements were taken under scotopic light conditions. The patient had both eyes open during measurements. The patient fixated with the eye to be measured at the red fixation light of the Pentacam system and was instructed to blink before every measurement. The automated release mode taking 25 pictures was used. Evaluation of potential diurnal variations in examination results was not peformed.
Statistical Analysis
According to the study by McAlinden et al, 18 inclusion of the right and left eyes from the same individual is 19 We also calculated the coefficient of variation (CV) using the tomographical data collected at the first visit. CV is the intrasubject SD divided by the overall mean and is expressed as a percentage. The Wilcoxon pairedsample test and Mann-Whitney U test were used to compare groups or variables. The Fisher exact test was used for the analysis of categorical data including proportions of patients classified as progressing. P , 0.05 was considered statistically significant for single parameter measurements. The Bonferroni correction was used to compensate for multiple comparisons. Logistic regression was used to calculate the likelihood that variation of repeated measurements would predict progression. To assess whether variability between repeated measurements of SimKast at the first visit could predict progression, the receiver operating characteristic (ROC) curve was created and the area under the curve was calculated.
Definition of Progression
An increase in simulated K astigmatism (SimKast) or one of the other K-readings studied (SimKmax, SimKave, Kmax3, Kmax5, and Kmax) of 1.0 D or more during the FU period or a decrease of MT by 2.5% or more was defined as significant. The relatively high threshold for progression based on the K-readings (+1 D over FU) was chosen to ensure selection of truly progressive eyes. We also chose this cutoff because it has been used in previous trials, although several authors advocate for the use of even higher thresholds. 20, 21 
RESULTS

Variability of Topography Measurements
High variability between repeated topography examinations in keratoconic eyes is well known, meaning that conclusions drawn from single measurements might be erroneous. Figures 1 and 2 show how the SD of the mean values of SimKast (SD_SimKast) and Kmax (SD_Kmax) of 3 measurements taken at the first visit increase dramatically as the mean value increased.
Therefore, as a first step, measurement variability between 3 consecutive measurements taken at the first visit in keratoconic eyes was analyzed. A high value regarding the within-subject SD (Sw) at 0.719 D was seen for Kmax3. Repeatability was generally poor with values for K-readings and simulated astigmatism ranging from 0.662 to 1.991 D. Repeatability was also poor at 10.6 mm for the MT measurement. The CV was highest for SimKast and MT at 11.5% and 14.3%, respectively. Sw, repeatability, and CV are summarized in Table 3 . As a next step, we investigated how variability of measurements affected the decision-making process, that is, whether to treat with CXL.
Impact of Measurement Variability on Analysis of Progression
Assessment of progression was based either on comparison of the first measurements at the first visit with those at the second visit ("F-protocol") or on comparison of the mean of 3 consecutive measurements at the first and second visits ("M-protocol").
As shown in Table 4 , the use of the F-or the Mprotocol for progression analysis led to different conclusions regarding progression. For example, for SimKast, considerably fewer eyes were classified as progressive using the Mprotocol compared with the F-protocol (4 and 9 eyes, respectively). Altough not statistically significant, the use of different protocols resulted in quite different numbers of patients subjected to CXL treatment. In this specific case, using the M-protocol would reduce the number of CXL treatments by 5 treatments for SimKast. In summary, diagnosis of progression of keratoconus may change considerably depending on which tomography parameters are used and whether the single or mean of repeated measurements are used for comparison.
Can the Variability of Consecutive SimKast Measurements Predict Progression?
Clinically, patients with higher variations in SimKast among the 3 consecutive measurements seemed to show progression at the second visit. To investigate this hypothesis, direct logistic regression was performed to assess the likelihood that variation of repeated measurements of the simulated central astigmatism (SD_SimKast) would predict progression. A significant fit of the final statistical model was indicated by x 2 7.336 (1, N = 80), P = 0.007. The model correctly identified 47.2% of cases. An increase in SD_SimKast of one unit, that is, 1 D, made true progression of keratoconus 3.6 times more likely (odds ratio = 3.6). Because of a wide 95% confidence interval (0.846-16.027) for the odds ratio, the conclusion regarding the level of effect was, however, rather unreliable. The size of the area under the ROC curve (area under the curve = 0.70) also indicates that the accuracy of predicting progression by the variation in repeated measurement of SimKast (ie, SD_SimKast) was poor. The ROC curve for SD_SimKast is shown in Figure 3 .
In conclusion, a high SD_SimKast at the first visit may be indicative of progression. However, based on the results of this small sample, it is a fairly weak indicator of progression.
DISCUSSION
Progression of keratoconus is not easily defined. 20 In earlier studies, different approaches to define progression have been used. They include measurement of changes in maximum keratometry readings, mean spherical equivalent, best-corrected spectacle distance visual acuity, contact lens distance visual acuity, and corneal thickness. 16 Best-corrected spectacle distance visual acuity and subjective refraction are, however, unreliable predictors when assessing progression of keratoconus and should not be used for that purpose. 4, 22 In 2015, the Global Consensus on Keratoconus and Ectatic Diseases defined criteria for progressive keratoconus. These included a consistent change in at least 2 of the following parameters: progressive steepening of the anterior corneal surface and progressive steepening of the posterior corneal surface, progressive thinning, and/or increase in the rate of corneal thickness change from the periphery to the thinnest point. The magnitude of the change must be above the normal noise of the testing system. 4 Despite a general consensus that progression of keratoconus should be defined by a change of several topographic parameters, one of the most common definitions of progression in clinical trials is an increase in only one parameter, the maximum keratometry reading (Kmax), by 1.0 D or more during different periods of FU. 4, 16 Furthermore, measurement variability as shown in this study and by other authors will make analysis of progression even more unreliable. Difficulty to fixate on the fixation light in the tomography machine is probably one of the main causes. 15 Still, practitioners often rely on single tomography examinations to assess progression of keratoconus. 16 Our analysis showed poor repeatability in general for most of the studied parameters. The results reflect the high variability of tomographic measurements in keratoconic eyes described by other authors. 14, 23 Within-subject SD (Sw) was poor for Kmax3 at 0.719 D and slightly better for Kmax5 at 0.417 D. Repeatability for anterior K-readings ranged between 0.662 D for SimKave and 1.991 D for the maximum Kmax, steepest radius of curvature on the anterior corneal surface; Kmax3, maximum keratometer reading on the 3-mm ring of the sagittal curvature map; Kmax5, maximum keratometer reading on the 5-mm ring of the sagittal curvature map; SimKast, absolute amount of anterior corneal astigmatism related to the Sim Ks; SimKave, arithmetic average of the central simulated K readings; SimKmax, maximum anterior simulated keratometer reading on a ring 15 degrees from the corneal apex; Sw, within-subject SD; repeatability, 2.77 · Sw. K-reading on the 3-mm ring (Kmax3 , Table 3 ). Hence, criteria for progression with an increase as low as 0.5 D over a certain period seem to be insufficient for the purpose of detecting "true" progression of the disease and not merely a numerical increase in measurement results. A recently published study by Prakash et al 21 came to the same conclusion. The authors recommended the curvature repeatability cutoff to be set as high as 1.25 D. In this context, keep in mind that that criteria for progression in clinical trials often include an increase in different K-readings by only 0.5 to 1.0 D. 21 Interestingly, in our study, SimKast had one of the highest CVs at 11.4%. This finding is comparable with the results of Prakash et al 21 for a CV of 7.2%. Prakash et al 21 also found a low CV of 0.4% for SimKave, which was confirmed in our study. As mentioned earlier, Kmax has been used as one of the central outcome variables in several studies evaluating the effect of CXL. 16 However, Kmax derived from the Pentacam has been shown to be prone to considerable variation in repeated measurements in keratoconic eyes. 20, 23 Consequently, Epstein et al recommended the use of an average of 5 past and 5 present measurements of Kmax for a more accurate representation of true corneal curvature change. With only one past and present measurement, Kmax change had to exceed 1.51 D to ensure a 95% confidence interval for a real Kmax change as compared to 0.68 D for the average of 5 past and 5 present measurements. 20 In a clinical setting, acquiring multiple measurements per eye at each visit is a tedious process both for patients and ophthalmic staff. In contrast to autorefractometers, this concept is not applied automatically to tomography machines for unknown reasons.
Epstein et al 20 also presented a combined statistic, "COMBO Statistic," for the evaluation of change in the steepest corneal curvature. The group, however, still recommends the use of Kmax as a good single criterion to diagnose progression or improvement of keratoconus.
Ideally, clinicians could rely on measurements of only one parameter at the first visit to predict progression. We analyzed whether the variation in SimKast of 3 consecutive measurements (SD_SimKast) at first could predict progression. We found SD_SimKast at the first visit to be indicative of progression. Based on the results of this small sample, it has, however, to be seen as a fairly weak indicator of progression. Further analysis of variability and combination of topographic parameters might render more robust protocols for analysis of progression.
It should be emphasized that the advent of new techniques for measurement of corneal biomechanics, such as Brillouin microscopy and air-puff deformation imaging (Ocular Response Analyzer, Reichert, Buffalo, NY, and CorVis, Oculus), might change the way we define and measure progression of ectatic diseases in the future. 24 One limitation of this study is a relatively small sample size. The power of the study was sufficient for analysis of repeatability. It failed, however, to show a statistically significant difference when comparing the F-and M-protocols for analysis of progression. Also, because 2 observers performed the tomography measurements, we cannot in a strict sense talk of an analysis of repeatability but rather of reproducibility of measurements. Since, however, the automated release mode was used for all measurements, this limitation was held to a minimum.
In conclusion, this study reflects a real-life clinical scenario with great impact for patients depending on which diagnostic protocol (single vs. repeated measurements) and which topographic parameter for detection of progression were used. Depending on which diagnostic approach is used, the number of CXL treatments will vary. A careful diagnostic approach and adherence to current guidelines for progression analysis are recommended.
